Information Library

Results for: Case Studies - Cost control/reduction

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title
  • Scaling Up for Safety: How to Gain Efficiencies without Sacrificing Quality

    September 16, 2010
    Read how Quintiles set-up a complete pharmacovigilance operation in a developing region in only six months for a leading pharma company.

  • Global Data Solutions

    September 15, 2010
    Quintiles leveraged its unmatched experience and regional presence to open a free-standing, closed source data management center of excellence.

  • Focused Co-Promotion

    May 9, 2010
    Roche Italy needed to find new, cost-effective ways to underpin sales of mature products. Uncover what happened when a unique partnership with Quintiles reinforced sales growth.

  • The Power of Consolidation: How to Gain Efficiencies without Sacrificing Quality

    March 31, 2010
    Biopharma companies are outsourcing more clinical trial services for greater cost efficiencies. Quintiles provides integrated services with one point of contact and streamlined management.

  • Maneuvering a Drifting Project Back on Course

    March 25, 2009
    The NDA had been drifting within the FDA for years, and now it was subject to intense scrutiny by two agency reviewers.

  • Antibiotic Safety Assessment

    March 25, 2009
    A major pharmaceutical company presented Quintiles with a pressing challenge – to collect extensive amounts of Phase IV data in compressed time windows because the treatment conditions were subject to seasonal variants.

  • Gain Capital & Retain Value

    March 24, 2009
    Cell Therapeutics was in need of capital to fund ongoing development expenses, but was not interested in further equity dilution. As an alternative, they considered monetizing a royalty interest in Trisenox®, their only marketed oncology product.

  • Matching Risks with Rewards

    March 24, 2009
    A global pharmaceutical company had a new formulation of a core strategic asset half way through its pivotal Phase III studies, but another major product launch at the company was generating such significant expenses that it was squeezing the budget for this and other development programs.

  • Project Coordination Centers

    March 20, 2009
    One day, a few years back, Quintiles dared to ask, “Why not?” Why not make investigators’ lives easier – and CRAs’ performance more efficient – by supplementing regular on-site visits with remote monitoring and investigator support?

Page 1 of 1 (9 results)

Subscribe to Email Based on Your Interests

Set preferences